By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics company T2 Biosystems today said it has closed its $23 million Series D financing round.

The funds will be used to support ongoing clinical trials and technology development as the company prepares to seek regulatory approval and commercialization of its T2MR diagnostic technology based on magnetic biosensor detection. The funding will also allow it to expand its partnering program, the Lexington, Mass.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.